COAGULATION FACTOR IX RECOMBINANT, GLYCOPEGYLATED

COAGULATION FACTOR IX RECOMBINANT, GLYCOPEGYLATED was reported 68 times

COAGULATION FACTOR IX RECOMBINANT, GLYCOPEGYLATED is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COAGULATION FACTOR LEVEL ABNORMAL 1 0.1667
1 ANTI FACTOR IX ANTIBODY INCREASED 2 0.1111
2 COAGULATION FACTOR IX LEVEL DECREASED 1 0.0175
3 FACTOR IX INHIBITION 1 0.0081
4 PLATELET DYSFUNCTION 1 0.0036
5 UROGENITAL HAEMORRHAGE 1 0.0027
6 PHYSICAL EXAMINATION ABNORMAL 1 0.0026
7 LYMPHATIC DISORDER 1 0.0017
8 CRANIOFACIAL FRACTURE 1 0.0012
9 MUSCLE SWELLING 1 0.0011
10 APPENDIX CANCER 1 0.0011
11 HAEMARTHROSIS 9 0.0010
12 BONE MARROW OEDEMA 1 0.0010
13 HAEMATOMA MUSCLE 1 0.0008
14 SUBCUTANEOUS HAEMATOMA 1 0.0008
15 MUSCLE HAEMORRHAGE 3 0.0007
16 TUNNEL VISION 1 0.0005
17 TRAUMATIC HAEMORRHAGE 1 0.0005
18 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
19 RENAL HAEMORRHAGE 1 0.0005
20 MOUTH HAEMORRHAGE 3 0.0004
21 THROMBOSIS IN DEVICE 1 0.0003
22 HAEMORRHAGIC DIATHESIS 1 0.0003
23 SPINAL STENOSIS 1 0.0002
24 IMMUNOSUPPRESSION 2 0.0002
25 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
26 ANORECTAL DISCOMFORT 1 0.0002
27 ANAL FISSURE 1 0.0002
28 POST PROCEDURAL HAEMORRHAGE 2 0.0002
29 HAEMOGLOBIN ABNORMAL 1 0.0002
30 UPPER LIMB FRACTURE 3 0.0002
31 LARGE INTESTINE POLYP 1 0.0001
32 APHTHOUS ULCER 1 0.0001
33 BLOOD DISORDER 1 0.0001
34 HEPATIC ENCEPHALOPATHY 1 0.0001
35 SUBARACHNOID HAEMORRHAGE 1 0.0001
36 POOR VENOUS ACCESS 1 0.0001
37 KNEE ARTHROPLASTY 2 0.0001
38 WOUND INFECTION 1 0.0001
39 ELECTROLYTE IMBALANCE 1 0.0001
40 SPLENOMEGALY 1 0.0001
41 GENITAL HAEMORRHAGE 1 0.0001
42 INFUSION SITE PAIN 1 0.0001
43 LIMB INJURY 2 0.0001
44 BLINDNESS UNILATERAL 1 0.0001
45 PULMONARY MASS 1 0.0001
46 HAEMORRHAGE 7 0.0001
47 THERAPEUTIC RESPONSE DECREASED 4 0.0001
48 BRAIN FOG 1 0.0001
49 HAEMATURIA 2 0.0001
50 COLD SWEAT 1 0.0001
51 OSTEOMYELITIS 1 0.0001
52 HEPATIC STEATOSIS 1 0.0001
53 HEPATIC CIRRHOSIS 1 0.0001
54 BLOOD URINE PRESENT 1 0.0001
55 JOINT INJURY 1 0.0000
56 ANAPHYLACTIC SHOCK 1 0.0000
57 HAEMATOMA 1 0.0000
58 ANAPHYLACTIC REACTION 2 0.0000
59 LIVER FUNCTION TEST ABNORMAL 1 0.0000
60 BLOOD POTASSIUM DECREASED 1 0.0000
61 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
62 CONTUSION 3 0.0000
63 CHOLELITHIASIS 1 0.0000
64 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
65 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
66 EPISTAXIS 2 0.0000
67 OSTEOPOROSIS 1 0.0000
68 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
69 FLUSHING 2 0.0000
70 SPEECH DISORDER 1 0.0000
71 DISTURBANCE IN ATTENTION 1 0.0000
72 SURGERY 1 0.0000
73 RHINORRHOEA 1 0.0000
74 INFUSION RELATED REACTION 1 0.0000
75 ERYTHEMA 3 0.0000
76 INJURY 1 0.0000
77 ARTHRITIS 1 0.0000
78 NASOPHARYNGITIS 2 0.0000
79 OROPHARYNGEAL PAIN 1 0.0000
80 CARDIAC DISORDER 1 0.0000
81 ATRIAL FIBRILLATION 1 0.0000
82 PRODUCT DOSE OMISSION ISSUE 3 0.0000
83 SYNCOPE 1 0.0000
84 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
85 ARTHRALGIA 4 0.0000
86 FALL 3 0.0000
87 SEPSIS 1 0.0000
88 MUSCULAR WEAKNESS 1 0.0000
89 INCORRECT DOSE ADMINISTERED 2 0.0000
90 ABDOMINAL PAIN 2 0.0000
91 LOSS OF CONSCIOUSNESS 1 0.0000
92 INFECTION 1 0.0000
93 HOSPITALISATION 1 0.0000
94 PERIPHERAL SWELLING 1 0.0000
95 HEADACHE 4 0.0000
96 TREMOR 1 0.0000
97 DIZZINESS 3 0.0000
98 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
99 HYPERSENSITIVITY 1 0.0000
100 ANAEMIA 1 0.0000
101 NAUSEA 4 0.0000
102 HYPOTENSION 1 0.0000
103 RASH 2 0.0000
104 WEIGHT INCREASED 1 0.0000
105 BACK PAIN 1 0.0000
106 DYSPNOEA 2 0.0000
107 CONDITION AGGRAVATED 1 0.0000
108 PRURITUS 1 0.0000
109 OFF LABEL USE 2 0.0000
110 MALAISE 1 0.0000
111 DRUG INEFFECTIVE 3 0.0000
112 VOMITING 1 0.0000
113 PAIN 1 0.0000
114 DIARRHOEA 1 0.0000
115 DEATH 1 0.0000